000 | 01747 a2200529 4500 | ||
---|---|---|---|
005 | 20250517090228.0 | ||
264 | 0 | _c20180712 | |
008 | 201807s 0 0 eng d | ||
022 | _a1473-0189 | ||
024 | 7 |
_a10.1039/c6lc00180g _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiu, X | |
245 | 0 | 0 |
_aHigh-throughput screening of antibiotic-resistant bacteria in picodroplets. _h[electronic resource] |
260 |
_bLab on a chip _c04 2016 |
||
300 |
_a1636-43 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 | _aCells, Immobilized |
650 | 0 | 4 | _aDrug Resistance, Bacterial |
650 | 0 | 4 | _aDrug Resistance, Multiple, Bacterial |
650 | 0 | 4 | _aEmulsions |
650 | 0 | 4 | _aEquipment Design |
650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
650 | 0 | 4 |
_aFusidic Acid _xpharmacology |
650 | 0 | 4 |
_aHigh-Throughput Screening Assays _xinstrumentation |
650 | 0 | 4 | _aLab-On-A-Chip Devices |
650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xinstrumentation |
650 | 0 | 4 |
_aMicrobial Viability _xdrug effects |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aParticle Size |
650 | 0 | 4 | _aProof of Concept Study |
650 | 0 | 4 |
_aProtein Synthesis Inhibitors _xpharmacology |
650 | 0 | 4 |
_aSingle-Cell Analysis _xinstrumentation |
650 | 0 | 4 | _aStereolithography |
700 | 1 | _aPainter, R E | |
700 | 1 | _aEnesa, K | |
700 | 1 | _aHolmes, D | |
700 | 1 | _aWhyte, G | |
700 | 1 | _aGarlisi, C G | |
700 | 1 | _aMonsma, F J | |
700 | 1 | _aRehak, M | |
700 | 1 | _aCraig, F F | |
700 | 1 | _aSmith, C A | |
773 | 0 |
_tLab on a chip _gvol. 16 _gno. 9 _gp. 1636-43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1039/c6lc00180g _zAvailable from publisher's website |
999 |
_c25881824 _d25881824 |